Craneware (#CRW) – emphasises some H1 improvement, “indication that sales cycles are shortening”

Craneware (#CRW) – “in line with management expectations”, Chairman appointment

Craneware – “short-term” sales performance issue & “continue to look to the future with high levels of confidence”. Really?

Craneware (CRW) has updated commencing that “the group has continued to make progress on its long-term strategic aim to become ubiquitous in US Hospitals, as the intelligence layer sitting across all other systems, delivering the information required to improve financial and operational performance” and including CEO Keith Neilson stating that “as we close our financial year, we continue to look to the future with high levels of confidence”. The shares are currently around 2000p (currently equating to circa $25.35) – Er… down more than 30%!...

Craneware (#CRW) – warns, H2 “timing and quantity of sales closed… have been lower than anticipated”

Craneware (#CRW) – “record results demonstrate the ongoing momentum”, further contract win

Craneware (#CRW) – H1 “continued to perform strongly” & confident in meeting FY expectations, contract win

Craneware (#CRW) v strong FY trading update, sales profit and cash generation all strongly ahead, balance sheet shows $50m cash

Craneware (#CRW) H1 Trading statement - says will meet forecasts, bullish

Craneware plc – positive momentum, but already priced in?

Leading provider of software in the US which helps hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies, Craneware plc (CRW) has updated that it has “confidence in meeting market expectations for the full year” and expects to report recognised revenue and EBITDA increases of 5% for the six months ended 31 December 2013 compared with the same period last fiscal year. Is there though much further upside in the shares, which at 550p, are up by more than 66% since a 26th June profit warning?

Craneware plc - AGM trading update & does recent deal read-across suggest value?

Craneware plc (CRW) has updated that “the strengthening of sales activity seen through the course of the previous year has continued and trading in the first few months of the new financial year has been healthy”. This has helped the shares up to 470p and having last commented on the company back in February HERE, the following updates…

Craneware – continuing to build a strong position in the US healthcare market?

Following from my piece on AIM-listed GB Group yesterday, I today comment on a fellow AIM-listed tech stock which also updated on trading towards the end of last month; Craneware plc (CRW). Despite its name and its being incorporated and headquartered in Scotland (Edinburgh), the company is actually a software provider focused on the US healthcare market. With offices in Atlanta, Arizona, Massachusetts and Tennessee, its software helps hospitals and other healthcare providers more effectively price, charge, code and retain revenue for patient care services and supplies – increasing their efficiency and minimising compliance risk. The following reviews the company’s recent trading update and investment outlook…